Close Menu

NEW YORK (GenomeWeb) – Korean RNAi drug developer OliX Pharmaceuticals, formerly known as Biomolecular Therapeutics, announced today that it has licensed its siRNA-based age-related macular degeneration drug to YuYu Pharma.

The drug, called OLX301, comprises OliX's proprietary self-delivering siRNAs. Under the terms of the arrangement, YuYu will take over the drug's development, manufacturing, and commercialization. In exchange, OliX is eligible to receive milestone payments based on the drug's development and regulatory approval, as well as tiered royalties on product sales.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.

Jun
04
Sponsored by
NanoCellect

This webinar will discuss a study that used CRISPR/Cas9 to engineer mice harboring risk variants associated with glaucoma in order to assess their functional relevance. 

Jun
06
Sponsored by
NRGene & Illumina

This webinar will discuss the impact of affordable de novo genome assemblies on crop research.